Quantification of cellular volume and sub-cellular density fluctuations: Comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient

Kevin G. Phillips, Anand Kolatkar, Kathleen J. Rees, Rachel Rigg, Dena Marrinucci, Madelyn Luttgen, Kelly Bethel, Peter Kuhn, Owen McCarty

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by the hematogenous transport of circulating tumor cells (CTCs) through the vasculature. Clinical studies have demonstrated that CTCs circulate in the blood of patients with metastatic disease across the major types of carcinomas, and that the number of CTCs in peripheral blood is correlated with overall survival in metastatic breast, colorectal, and prostate cancer. While the potential to monitor metastasis through CTC enumeration exists, the basic physical features of CTCs remain ill defined and moreover, the corresponding clinical utility of these physical parameters is unknown. To elucidate the basic physical features of CTCs we present a label-free imaging technique utilizing differential interference contrast (DIC) microscopy to measure cell volume and to quantify sub-cellular mass-density variations as well as the size of subcellular constituents from mass-density spatial correlations. DIC measurements were carried out on CTCs identified in a breast cancer patient using the high-definition (HD) CTC detection assay. We compared the biophysical features of HD-CTC to normal blood cell subpopulations including leukocytes, platelets (PLT), and red blood cells (RBCs). HD-CTCs were found to possess larger volumes, decreased mass-density fluctuations, and shorter-range spatial density correlations in comparison to leukocytes. Our results suggest that HD-CTCs exhibit biophysical signatures that might be used to potentially aid in their detection and to monitor responses to treatment in a label-free fashion. The biophysical parameters reported here can be incorporated into computational models of CTC-vascular interactions and in vitro flow models to better understand metastasis.

Original languageEnglish (US)
Article numberArticle 96
JournalFrontiers in Oncology
Volume2 AUG
DOIs
StatePublished - 2012

Fingerprint

Circulating Neoplastic Cells
Blood Cells
Breast Neoplasms
Neoplasm Metastasis
Leukocytes
Interference Microscopy
Cell Size
Cell Communication
Blood Vessels
Colorectal Neoplasms
Neoplasms
Prostatic Neoplasms

Keywords

  • Breast cancer
  • Cellular density
  • Cellular volume
  • Circulating tumor cells
  • Differential interference contrast microscopy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Quantification of cellular volume and sub-cellular density fluctuations : Comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. / Phillips, Kevin G.; Kolatkar, Anand; Rees, Kathleen J.; Rigg, Rachel; Marrinucci, Dena; Luttgen, Madelyn; Bethel, Kelly; Kuhn, Peter; McCarty, Owen.

In: Frontiers in Oncology, Vol. 2 AUG, Article 96, 2012.

Research output: Contribution to journalArticle

Phillips, Kevin G. ; Kolatkar, Anand ; Rees, Kathleen J. ; Rigg, Rachel ; Marrinucci, Dena ; Luttgen, Madelyn ; Bethel, Kelly ; Kuhn, Peter ; McCarty, Owen. / Quantification of cellular volume and sub-cellular density fluctuations : Comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. In: Frontiers in Oncology. 2012 ; Vol. 2 AUG.
@article{fd59d804966047d7949aa7fb036097c7,
title = "Quantification of cellular volume and sub-cellular density fluctuations: Comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient",
abstract = "Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by the hematogenous transport of circulating tumor cells (CTCs) through the vasculature. Clinical studies have demonstrated that CTCs circulate in the blood of patients with metastatic disease across the major types of carcinomas, and that the number of CTCs in peripheral blood is correlated with overall survival in metastatic breast, colorectal, and prostate cancer. While the potential to monitor metastasis through CTC enumeration exists, the basic physical features of CTCs remain ill defined and moreover, the corresponding clinical utility of these physical parameters is unknown. To elucidate the basic physical features of CTCs we present a label-free imaging technique utilizing differential interference contrast (DIC) microscopy to measure cell volume and to quantify sub-cellular mass-density variations as well as the size of subcellular constituents from mass-density spatial correlations. DIC measurements were carried out on CTCs identified in a breast cancer patient using the high-definition (HD) CTC detection assay. We compared the biophysical features of HD-CTC to normal blood cell subpopulations including leukocytes, platelets (PLT), and red blood cells (RBCs). HD-CTCs were found to possess larger volumes, decreased mass-density fluctuations, and shorter-range spatial density correlations in comparison to leukocytes. Our results suggest that HD-CTCs exhibit biophysical signatures that might be used to potentially aid in their detection and to monitor responses to treatment in a label-free fashion. The biophysical parameters reported here can be incorporated into computational models of CTC-vascular interactions and in vitro flow models to better understand metastasis.",
keywords = "Breast cancer, Cellular density, Cellular volume, Circulating tumor cells, Differential interference contrast microscopy",
author = "Phillips, {Kevin G.} and Anand Kolatkar and Rees, {Kathleen J.} and Rachel Rigg and Dena Marrinucci and Madelyn Luttgen and Kelly Bethel and Peter Kuhn and Owen McCarty",
year = "2012",
doi = "10.3389/fonc.2012.0096",
language = "English (US)",
volume = "2 AUG",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Quantification of cellular volume and sub-cellular density fluctuations

T2 - Comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient

AU - Phillips, Kevin G.

AU - Kolatkar, Anand

AU - Rees, Kathleen J.

AU - Rigg, Rachel

AU - Marrinucci, Dena

AU - Luttgen, Madelyn

AU - Bethel, Kelly

AU - Kuhn, Peter

AU - McCarty, Owen

PY - 2012

Y1 - 2012

N2 - Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by the hematogenous transport of circulating tumor cells (CTCs) through the vasculature. Clinical studies have demonstrated that CTCs circulate in the blood of patients with metastatic disease across the major types of carcinomas, and that the number of CTCs in peripheral blood is correlated with overall survival in metastatic breast, colorectal, and prostate cancer. While the potential to monitor metastasis through CTC enumeration exists, the basic physical features of CTCs remain ill defined and moreover, the corresponding clinical utility of these physical parameters is unknown. To elucidate the basic physical features of CTCs we present a label-free imaging technique utilizing differential interference contrast (DIC) microscopy to measure cell volume and to quantify sub-cellular mass-density variations as well as the size of subcellular constituents from mass-density spatial correlations. DIC measurements were carried out on CTCs identified in a breast cancer patient using the high-definition (HD) CTC detection assay. We compared the biophysical features of HD-CTC to normal blood cell subpopulations including leukocytes, platelets (PLT), and red blood cells (RBCs). HD-CTCs were found to possess larger volumes, decreased mass-density fluctuations, and shorter-range spatial density correlations in comparison to leukocytes. Our results suggest that HD-CTCs exhibit biophysical signatures that might be used to potentially aid in their detection and to monitor responses to treatment in a label-free fashion. The biophysical parameters reported here can be incorporated into computational models of CTC-vascular interactions and in vitro flow models to better understand metastasis.

AB - Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by the hematogenous transport of circulating tumor cells (CTCs) through the vasculature. Clinical studies have demonstrated that CTCs circulate in the blood of patients with metastatic disease across the major types of carcinomas, and that the number of CTCs in peripheral blood is correlated with overall survival in metastatic breast, colorectal, and prostate cancer. While the potential to monitor metastasis through CTC enumeration exists, the basic physical features of CTCs remain ill defined and moreover, the corresponding clinical utility of these physical parameters is unknown. To elucidate the basic physical features of CTCs we present a label-free imaging technique utilizing differential interference contrast (DIC) microscopy to measure cell volume and to quantify sub-cellular mass-density variations as well as the size of subcellular constituents from mass-density spatial correlations. DIC measurements were carried out on CTCs identified in a breast cancer patient using the high-definition (HD) CTC detection assay. We compared the biophysical features of HD-CTC to normal blood cell subpopulations including leukocytes, platelets (PLT), and red blood cells (RBCs). HD-CTCs were found to possess larger volumes, decreased mass-density fluctuations, and shorter-range spatial density correlations in comparison to leukocytes. Our results suggest that HD-CTCs exhibit biophysical signatures that might be used to potentially aid in their detection and to monitor responses to treatment in a label-free fashion. The biophysical parameters reported here can be incorporated into computational models of CTC-vascular interactions and in vitro flow models to better understand metastasis.

KW - Breast cancer

KW - Cellular density

KW - Cellular volume

KW - Circulating tumor cells

KW - Differential interference contrast microscopy

UR - http://www.scopus.com/inward/record.url?scp=84874117034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874117034&partnerID=8YFLogxK

U2 - 10.3389/fonc.2012.0096

DO - 10.3389/fonc.2012.0096

M3 - Article

AN - SCOPUS:84874117034

VL - 2 AUG

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - Article 96

ER -